EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 7-Nov-2025 01:11 ET (7-Nov-2025 06:11 GMT/UTC)

9-Oct-2025

City of Hope Research Spotlight, September 2025

City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, life-threatening diseases. Each spotlight features research-related news such as recognitions, collaborations and the latest research defining the future of medical treatment.

Journal: Nature Genetics

9-Oct-2025

Lung cancer incidence after September 11, 2001, among World Trade Center responders

JAMA Network
Peer-Reviewed Publication

About The Study: The results of this study of World Trade Center (WTC) responders suggests that, when compared with the lowest reported exposure levels, a higher level of reported exposure to more particulate dust or debris was significantly associated with an increased incidence of lung cancer. Future studies may investigate specific WTC exposures and histologic changes and clarify the role of WTC exposure for prognosis.

Journal: JAMA Network Open

9-Oct-2025

UMass Amherst researchers create nanoparticle vaccine that prevents cancer in mice

University of Massachusetts Amherst
Peer-Reviewed Publication

AMHERST, Mass. — A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice. Not only did up to 88% of the vaccinated mice remain tumor-free (depending on the cancer), but the vaccine reduced—and in some cases completely prevented—the cancer’s spread.

Journal: Cell Reports Medicine
Funder: NIH/National Institutes of Health, NIH/National Cancer Institute

9-Oct-2025

AIM-HI Accelerator Fund announces winners of the 2025 Venture Competition

AIM-HI Accelerator Fund
Grant and Award Announcement

In its mission to accelerate transformative cancer innovations and drive cures forward, the AIM-HI Accelerator Fund is pleased to announce the winners of the 2025 AIM-HI Venture Competition: ResNovas Therapeutics, co-founded by Nobel Laureate Carolyn Bertozzi, Ph.D., Michelle Arkin, Ph.D., CTO Ian Churcher, Ph.D., and CEO Gabriele Sulli, Ph.D.; and Chiara Biosciences, co-founded by National Academy of Inventors Fellow Francis Barany, Ph.D. and CEO Kirsten Flowers, MBA.

9-Oct-2025

It’s never too late for those with cancer to quit smoking

WashU Medicine
Peer-Reviewed Publication

A smoking cessation program developed by WashU Medicine researchers and deployed at Siteman Cancer Center prolongs life for cancer patients, according to a new study. Regardless of their type of cancer or how advanced it was, cancer patients lived nearly a year longer when they quit smoking compared to patients who continued smoking.

Journal: Journal of the National Comprehensive Cancer Network
Funder: NIH/National Cancer Institute, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, U.S. Department of Defense, Alvin J. Siteman Cancer Center Siteman Investment Program

9-Oct-2025

New JNCCN study confirms it’s ‘never too late’ to see survival benefits from quitting smoking—even with late-stage cancer

National Comprehensive Cancer Network
Peer-Reviewed Publication

New research in JNCCN—Journal of the National Comprehensive Cancer Network finds that people with cancer who quit smoking had a much lower risk of dying within two years compared to those who kept smoking. The survival benefit was seen across all cancer types and stages, including stages III and IV.

Journal: Journal of the National Comprehensive Cancer Network

8-Oct-2025

Nurses step up to tackle Australia’s skin cancer crisis

University of South Australia
Peer-Reviewed Publication

Australia needs to be innovative when it comes to skin cancer detection by embracing a nurse-led model that could save thousands of lives in the long run, according to a new paper.